BMJ 1997;315:1502-1504 (6 December)

Papers

Case-control study of oral contraceptives and risk of thromboembolic stroke: results from international study on oral contraceptives and health of young women

Lothar A J Heinemann, director and professor,a Michael A Lewis, director,b Margaret Thorogood, reader,c Walter O Spitzer, professor emeritus,d Irene Guggenmoos-Holzmann, director and professor,e Rudolf Bruppacher, professor f

a ZEG-Centre for Epidemiology and Health Research Berlin, D-16341 Zepernick, Germany, b EPES Epidemiology Pharmaco-epidemiology and Systems Research, D-12165 Berlin, Germany, c Health Promotion Sciences Unit, London School of Hygiene and Tropical Medicine, London WC1E 7HT, d Department of Epidemiology and Biostatistics, McGill University Montreal, QC, Canada H3A 1A2, e Institute of Medical Statistics, Epidemiology and Informatics, Free University Berlin, D-12200 Berlin, Germany, f University Basle, CH-4310 Rheinfelden, Switzerland,

Correspondence to: Professor Heinemann

Objective: To determine the influence of oral contraceptives (particularly those containing modern progestins) on the risk for ischaemic stroke in women aged 16-44 years.
Design: Matched case-control study.
Setting: 16 centres in the United Kingdom, Germany, France, Switzerland, and Austria.
Subjects: Cases were 220 women aged 16-44 who had an incident ischaemic stroke. Controls were 775 women ( at least one hospital and one community control per case) unaffected by stroke who were matched with the corresponding case for 5 year age band and for hospital or community setting. Information on exposure and confounding variables were collected in a face to face interview.
Main outcome measures: Odds ratios derived with stratified analyses and unconditional logistic regression to adjust for potential confounding.
Results: Adjusted odds ratios (95% confidence intervals) for ischaemic stroke (unmatched analysis) were 4.4 (2.0 to 9.9), 3.4 ( 2.1 to 5.5), and 3.9 (2.3 to 6.6) for current use of first, second, and third generation oral contraceptives, respectively. The risk ratio for third versus second generation was 1.1 (0.7 to 2.0) and was similar in the United Kingdom and other European countries. The risk estimates were lower if blood pressure was checked before prescription.
Conclusion: Although there is a small relative risk of occlusive stroke for women of reproductive age who currently use oral contraceptives, the attributable risk is very small because the incidence in this age range is very low. There is no difference between the risk of oral contraceptives of the third and second generation; only first generation oral contraceptives seem to be associated with a higher risk. This small increase in risk may be further reduced by efforts to control cardiovascular risk factors, particularly high blood pressure.

Key messages

  • This study shows a slightly increased relative risk of thromboembolic stroke in women currently using oral contraceptives compared with women not using them. The high dose oestrogen pills carry a higher risk than the low dose formulations, irrespective of the type of progestin

  • The absolute risk of occlusive stroke for women who currently use modern oral contraceptives is very small—that is, the incidence in this age range is very low and not different between second and third generation oral contraceptives

  • This small increase in risk can be controlled by avoiding prescription of oral contraceptives to women who have evidence of cardiovascular disease, in particular high blood pressure


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Drug use in children: cohort study in three European countries
Miriam C J M Sturkenboom, Katia M C Verhamme, Alfredo Nicolosi, Macey L Murray, Antje Neubert, Daan Caudri, Gino Picelli, Elif Fatma Sen, Carlo Giaquinto, Luigi Cantarutti, Paola Baiardi, Maria-Grazia Felisi, Adriana Ceci, Ian C K Wong on behalf of the TEDDY European Network of Excellence
BMJ 2008 337: a2245. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Sturkenboom, M. C J M, Verhamme, K. M C, Nicolosi, A., Murray, M. L, Neubert, A., Caudri, D., Picelli, G., Sen, E. F., Giaquinto, C., Cantarutti, L., Baiardi, P., Felisi, M.-G., Ceci, A., Wong, I. C K, on behalf of the TEDDY European Network of Excelle, (2008). Drug use in children: cohort study in three European countries. BMJ 337: a2245-a2245 [Abstract] [Full text]  
  • Goldstein, L. B., Adams, R., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C. D., Culebras, A., DeGraba, T. J., Gorelick, P. B., Guyton, J. R., Hart, R. G., Howard, G., Kelly-Hayes, M., Nixon, J.V., Sacco, R. L. (2006). Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.. Circulation 113: e873-e923 [Abstract] [Full text]  
  • Goldstein, L. B., Adams, R., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C. D., Culebras, A., DeGraba, T. J., Gorelick, P. B., Guyton, J. R., Hart, R. G., Howard, G., Kelly-Hayes, M., Nixon, J.V., Sacco, R. L. (2006). Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.. Stroke 37: 1583-1633 [Abstract] [Full text]  
  • Chan, W.-S., Ray, J., Wai, E. K., Ginsburg, S., Hannah, M. E., Corey, P. N., Ginsberg, J. S. (2004). Risk of Stroke in Women Exposed to Low-Dose Oral Contraceptives: A Critical Evaluation of the Evidence. Arch Intern Med 164: 741-747 [Abstract] [Full text]  
  • Vandenbroucke, J. P., Rosing, J., Bloemenkamp, K. W.M., Middeldorp, S., Helmerhorst, F. M., Bouma, B. N., Rosendaal, F. R. (2001). Oral Contraceptives and the Risk of Venous Thrombosis. NEJM 344: 1527-1535 [Full text]  
  • Goldstein, L. B., Adams, R., Becker, K., Furberg, C. D., Gorelick, P. B., Hademenos, G., Hill, M., Howard, G., Howard, V. J., Jacobs, B., Levine, S. R., Mosca, L., Sacco, R. L., Sherman, D. G., Wolf, P. A., del Zoppo, G. J., Members, (2001). Primary Prevention of Ischemic Stroke : A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association. Circulation 103: 163-182 [Full text]  
  • Goldstein, L. B., Adams, R., Becker, K., Furberg, C. D., Gorelick, P. B., Hademenos, G., Hill, M., Howard, G., Howard, V. J., Jacobs, B., Levine, S. R., Mosca, L., Sacco, R. L., Sherman, D. G., Wolf, P. A., del Zoppo, G. J. (2001). Primary Prevention of Ischemic Stroke : A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association. Stroke 32: 280-299 [Full text]  
  • Mira, Y., Aznar, J., Estelles, A., Vaya, A., Villa, P., Ferrando, F. (2000). State-of-the-Art Review : Congenital and Acquired Thrombotic Risk Factors in Women Using Oral Contraceptives: Clinical Aspects. CLIN APPL THROMB HEMOST 6: 162-168 [Abstract]  
  • , T. E. C. W. G. (2000). Screening before and during the use of oral contraceptives and hormone replacement therapy. Hum Reprod 15: 485-492 [Abstract] [Full text]  
  • Lewis, M. A., MacRae, K. D., Kuhl-Habich1, D., Bruppacher, R., Heinemann, L. A.J., Spitzer, W. O. (1999). The differential risk of oral contraceptives: the impact of full exposure history. Hum Reprod 14: 1493-1499 [Abstract] [Full text]  
  • (1998). More on OCs and Thromboembolic Stroke. JWatch Women's Health 1998: 8-8 [Full text]  
  • (1998). ORAL CONTRACEPTIVES AND RISK FOR ISCHEMIC STROKE. JWatch General 1998: 7-7 [Full text]  



Access jobs at BMJ Careers
Whats new online at Student 

BMJ